Reduced expression of the cadherin-catenin complex in oesophageal adenocarcinoma correlates with poor prognosis

Journal of Pathology

Volumn 182, Issue 3, 1997, Pages 331-338

  Krishnadath, Kausilia K ^a   Tilanus, Hugo W ^a   Van Blankenstein, Mark ^a   Hop, Willem C J ^a   Kremers, Elisa D ^a   Dinjens, Winand N M ^a   Bosman, Fred T ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Catenins; E cadherin; Oesophageal adenocarcinoma; Survival

Indexed keywords

ALPHA CATENIN; BETA CATENIN; CATENIN; CELL ADHESION MOLECULE; UVOMORULIN;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER INVASION; CONTROLLED STUDY; ESOPHAGUS CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROGNOSIS;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BARRETT ESOPHAGUS; CADHERINS; CASE-CONTROL STUDIES; ESOPHAGEAL NEOPLASMS; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; SURVIVAL ANALYSIS;

EID: 0030852218     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199707)182:3<331::AID-PATH860>3.0.CO;2-D     Document Type: Article

References (50)

1. Reed PI, Johnston BJ. The changing incidence of oesophageal cancer. Endoscopy 1993; 25: 606-608.
2. Cameron AJ, Ott BJ, Payne WS. The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus. N Engl J Med 1985; 313: 857-859.
3. Van der Veen AH, Dees J, Blankensteijn JD, Van Blankenstein M. Adenocarcinoma in Barrett's oesophagus: an overrated risk. Gut 1989; 30: 14-18.
4. Reid BJ, Blount PL, Rubin CE, Levine DS, Haggitt RC, Rabinovitch PS. Flow-cytometric and histological progression to malignancy in Barrett's esophagus: prospective endoscopie surveillance of a cohort. Gastroenterology 1992; 102: 1212-1219.
5. Haggitt RC. Barrett's esophagus, dysplasia, and adenocarcinoma (Review). Hum Pathol 1994; 25: 982-993.
6. Menke-Pluymers MB, Schoute NW, Mulder AH, Hop WC, van Blankenstein M, Tilanus HW. Outcome of surgical treatment of adenocarcinoma in Barrett's oesophagus. Gut 1992; 33: 1454-1458.
7. Lerut T, De Leyn P, Coosemans W, Lesaffre E. Surgery for esophageal carcinoma. J Belge Radiol 1991; 74: 389-396.
8. Takeichi M. The cadherin cell adhesion receptor family: roles in multicellular organization and neurogenesis (Review). Prog Clin Biol Res 1994; 390: 145-153.
9. Rimm DL, Morrow JS. Molecular cloning of human E-cadherin suggests a novel subdivision of the cadherin superfamily. Biochem Biophys Res Commun 1994; 200: 1754-1761.
10. Shapiro L, Fannon AM, Kwong PD, et al. Structural basis of cell-cell adhesion by cadherins. Nature 1995; 374: 327-337.
11. Damsky CH, Richa J, Solter D, Knudsen K, Buck CA. Identification and purification of a cell surface glycoprotein mediating intercellular adhesion in embryonic and adult tissue. Cell 1983; 34: 455-466.
12. Hyafil F, Morallo D, Babinet C, Jacob F. A cell surface molecule glycoprotein involved in compaction of embryonal carcinoma cells and cleavage stage embryos. Cell 1980; 21: 927-934.
13. Behrens J, Mareel MM, Van Roy F, Birchmeier W. Dissecting tumor cell invasion: epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion. J Cell Biol 1989; 108: 2435-2447.
14. Vleminckx K, Vakaet L Jr, Mareel M, Fiers W, van Roy F. Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell 1991; 66: 107-119.
15. Behrens J. Cadherins as determinants of tissue morphology and suppressors of invasion (Review). Acta Anat 1994; 149: 165-169.
16. Ozawa M, Baribault H, Kemler R. The cytoplasmic domain of the cell adhesion molecule uvomorulin associates with three independent proteins structurally related in different species. EMBO J 1989; 8: 1711-1717.
17. Ozawa M, Ringwald M, Kemler R. Uvomorulin-catenin complex formation is regulated by a specific domain in the cytoplasmic region of the cell adhesion molecule. Proc Natl Acad Sci USA 1990; 87: 4246-4250.
18. Rubinfeld B, Souza B, Albert I, et al. Association of the APC gene product with beta-catenin. Science 1993; 262: 1731-1734.
19. Su LK, Vogelstein B, Kinzler KW. Association of the APC tumor suppressor protein with catenins. Science 1993; 262: 1734-1737.
20. Kanai Y, Ochiai A, Shibata T, et al. c-erbB-2 gene product directly associates with beta-catenin and plakoglobin. Biochem Biophys Res Commun 1995; 208: 1067-1072.
21. Umbas R, Schalken JA, Aalders TW, et al. Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer. Cancer Res 1992; 52: 5104-5109.
22. Morton RA, Ewing CM, Nagafuchi A, Tsukita S, Isaacs WB. Reduction of E-cadherin levels and deletion of the alpha-catenin gene in human prostate cancer cells. Cancer Res 1993; 53: 3585-3590.
23. Rimm DL, Sinard JH, Morrow JS. Reduced alpha-catenin and E-cadherin expression in breast cancer. Lab Invest 1995; 72: 506-512.
24. Bongiorno PF, al-Kasspooles M, Lee SW, et al. E-cadherin expression in primary and metastatic thoracic neoplasms and in Barrett's oesophagus. Br J Cancer 1995; 71: 166-172.
25. Shiozaki H, Tahara H, Oka H, et al. Expression of immunoreactive E-cadherin adhesion molecules in human cancers. Am J Pathol 1991; 139: 17-23.
26. Shiozaki H, lihara K, Oka H, et al. Immunohistochemical detection of alpha-catenin expression in human cancers. Am J Pathol 1994; 144: 667-674.
27. Matsui S, Shiozaki H, Inoue M, et al. Immunohistochemical evaluation of alpha-catenin expression in human gastric cancer. Virchows Arch 1994; 424: 375-381.
28. Kadowaki T, Shiozaki H, Inoue M, et al. E-cadherin and alpha-catenin expression in human esophageal cancer. Cancer Res 1994; 54: 291-296.
29. Schipper JH, Frixen UH, Behrens J, Unger A, Jahnke K, Birchmeier W. E-cadherin expression in squamous cell carcinomas of head and neck: inverse correlation with tumor dedifferentiation and lymph node metastasis. Cancer Res 1991; 51: 6328-6337.
30. Takayama T, Shiozaki H, Shibamoto S, et al. Beta-catenin expression in human cancers. Am J Pathol 1996; 148: 39-47.
31. Frixen UH, Behrens J, Sachs M, el al. E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 1991; 113: 173-185.
32. Piepenhagen PA, Nelson WJ. Defining E-cadherin-associated protein complexes in epithelial cells: plakoglobin, beta-and gamma-catenin are distinct components. J Cell Sci 1993; 104: 751-762.
33. Boller K, Vestweber D, Kemler R. Cell-adhesion uvomorulin is localized in the intermediate junctions of adult intestinal epithelial cells. J Cell Biol 1985; 100: 327-332.
34. Takeichi M. Cadherin cell adhesion receptors as a morphogenetic regulator (Review). Science 1991; 251: 1451-1455.
35. Nagafuchi A, Takeichi M. Cell binding function of E-cadherin is regulated by the cytoplasmic domain. EMBO J 1988; 7: 3679-3684.
36. Becker KF, Atkinson MJ, Reich U, et al. E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res 1994; 54: 3845-3852.
37. Berx G, Cleton-Jansen A, Nollet F, et al. E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers. EMBO J 1995; 14: 6107-6115.
38. Breen E, Clarke A, Steele G Jr, Mercurio AM. Poorly differentiated colon carcinoma cell lines deficient in alpha-catenin expression express high levels of surface E-cadherin but lack Ca(2+)-dependent cell-cell adhesion. Cell Adhes Commun 1993; 1: 239-250.
39. Hulsken J, Birchmeier W, Behrens J. E-cadherin and APC compete for the interaction with beta-catenin and the cytoskeleton. J Cell Biol 1994; 127: 2061-2069.
40. Hoscheutzky H, Aberle H, Kemler R. Beta-catenin mediates the interaction of the cadherin-catenin complex with epidermal growth factor receptor. J Cell Biol 1995; 127: 1375-1380.
41. Aghib DF, McCrea PD. The E-cadherin complex contains the src substrate p120. Exp Cell Res 1995; 218: 359-369.
42. Behrens J, Vakaet L, Friis R, et al. Loss of epithelial differentiation and gain of invasiveness correlates with tyrosine phosphorylation of the E-cadherin/ beta-catenin complex in cells transformed with a temperature-sensitive v-SRC gene. J Cell Biol 1993; 120: 757-766.
43. Nakamura T, Nekarda H, Hoelscher AH, et al. Prognostic value of DNA ploidy and c-erbB-2 oncoprotein overexpression in adenocarcinoma of Barrett's esophagus. Cancer 1994; 73: 1785-1794.
44. Jankowski J, Coghill G, Hopwood D, Wormsley KG. Oncogenes and onco-suppressor gene in adenocarcinoma of the oesophagus. Gut 1992; 33: 1033-1038.
45. Al-Kaspooles M, Moore JH, Orringer MB. Amplification and overexpression of the EGFR and erbB-2 genes in human esophageal adenocarcinomas. Int J Cancer 1993; 54: 213-219.
46. Blount PL, Meltzer SJ, Yin J, Huang Y, Krasna MJ, Reid BJ. Clonal ordering of 17p and 5q allelic losses in Barrett dysplasia and adenocarcinoma. Proc Natl Acad Sci USA 1993; 90: 3221-3225.
47. Barrett MT, Galipeau PC, Sanchez CA, Emond MJ, Reid BJ. Determination of the frequency of loss of heterozygosity in esophageal adenocarcinoma by cell sorting, whole genome amplification and microsatellite polymorphisms. Oncogene 1996; 12: 1873-1878.
48. Zhuang Z, Vortmeyer AO, Mark EJ, et al. Barrett's esophagus: metaplastic cells with loss of heterozygosity at the APC gene locus are clonal precursors to invasive adenocarcinoma. Cancer Res 1996; 56: 1961-1964.
49. Powell SM, Papadoupoulos N, Kinzler KW, Smolinkski KN, Meltzer MJ. APC gene mutations in the mutation cluster region are rare in esophageal cancers. Gastroenterology 1994; 107:.
50. Ochiai A, Akimoto S, Shimoyama Y, Nagafuchi A, Tsukita S, Hirohashi S. Frequent loss of alpha catenin expression in scirrhous carcinomas with scattered cell growth. Jpn J Cancer Res 1994; 85: 266-273.